160 related articles for article (PubMed ID: 33165302)
1. TRIPLE THERAPY WITH RITUXIMAB, INTRAVENOUS IMMUNOGLOBULIN, AND INTRAVITREAL CORTICOSTEROIDS FOR MELANOMA-ASSOCIATED RETINOPATHY: TTRIIC DOES THE TRICK.
Hamdan SA; Breazzano MP; Daniels AB
Retin Cases Brief Rep; 2022 Nov; 16(6):775-778. PubMed ID: 33165302
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
3. Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone.
Poujade L; Samaran Q; Mura F; Guillot B; Meunier I; Du-Thanh A
Doc Ophthalmol; 2021 Apr; 142(2):257-263. PubMed ID: 32975694
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma-associated retinopathy in a young teenager with immature teratoma of the ovary.
Turaka K; Kietz D; Krishnamurti L; Mitchell E; Scanga H; Fu VL; Sylvester C
J AAPOS; 2014 Aug; 18(4):396-8. PubMed ID: 25173906
[TBL] [Abstract][Full Text] [Related]
5. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
Guy J; Aptsiauri N
Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach.
Dalal MD; Morgans CW; Duvoisin RM; Gamboa EA; Jeffrey BG; Garg SJ; Chan CC; Sen HN
Ophthalmology; 2013 Dec; 120(12):2560-2564. PubMed ID: 24053997
[TBL] [Abstract][Full Text] [Related]
7. Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin.
Subhadra C; Dudek AZ; Rath PP; Lee MS
J Neuroophthalmol; 2008 Mar; 28(1):23-6. PubMed ID: 18347454
[TBL] [Abstract][Full Text] [Related]
8. Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.
Roels D; Ueno S; Talianu CD; Draganova D; Kondo M; Leroy BP
Doc Ophthalmol; 2017 Dec; 135(3):233-240. PubMed ID: 28815346
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated Retinopathy and Treatment with Intravenous Immunoglobulin Therapy. A Seldom Used Approach?
Ramos-Ruperto L; Busca-Arenzana C; Boto-de Los Bueis A; Schlincker A; Arnalich-Fernández F; Robles-Marhuenda Á
Ocul Immunol Inflamm; 2021 Feb; 29(2):399-402. PubMed ID: 31710513
[No Abstract] [Full Text] [Related]
10. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to transient receptor potential cation channel, subfamily M, member 1 in a Japanese patient with melanoma-associated retinopathy.
Morita Y; Kimura K; Fujitsu Y; Enomoto A; Ueno S; Kondo M; Sonoda KH
Jpn J Ophthalmol; 2014 Mar; 58(2):166-71. PubMed ID: 24468869
[TBL] [Abstract][Full Text] [Related]
12. NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORT.
Garcia CM; Maleki A; Look-Why S; Manhapra A; Durrani K; Foster CS
Retin Cases Brief Rep; 2023 Jul; 17(4):384-388. PubMed ID: 34618714
[TBL] [Abstract][Full Text] [Related]
13. Lesson of the month 1: Seeing snowflakes.
Patel A; Aslam A; Orr G; Perkins W
Clin Med (Lond); 2015 Aug; 15(4):394-5. PubMed ID: 26407395
[TBL] [Abstract][Full Text] [Related]
14. Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.
Stead RE; Fox MA; Staples E; Lim CS
Doc Ophthalmol; 2013 Oct; 127(2):165-71. PubMed ID: 23794161
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
Keltner JL; Thirkill CE; Yip PT
J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
[TBL] [Abstract][Full Text] [Related]
16. Melanoma-associated retinopathy treated with ipilimumab therapy.
Audemard A; de Raucourt S; Miocque S; Comoz F; Giraud JM; Dreno B; Bienvenu B; Rogerie MJ; Dompmartin A
Dermatology; 2013; 227(2):146-9. PubMed ID: 24051549
[TBL] [Abstract][Full Text] [Related]
17. CHOROIDAL NEOVASCULARIZATION AND CHORIORETINAL ATROPHY IN A PATIENT WITH MELANOMA-ASSOCIATED RETINOPATHY AFTER IPILIMUMAB/NIVOLUMAB COMBINATION THERAPY.
Elwood KF; Pulido JS; Ghafoori SD; Harper CA; Wong RW
Retin Cases Brief Rep; 2021 Sep; 15(5):514-518. PubMed ID: 31246886
[TBL] [Abstract][Full Text] [Related]
18. Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction.
Hung WC; Cheng HC; Wang AG
Doc Ophthalmol; 2022 Dec; 145(3):263-270. PubMed ID: 36173494
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cancer-associated retinopathy with rituximab.
Dy I; Chintapatla R; Preeshagul I; Becker D
J Natl Compr Canc Netw; 2013 Nov; 11(11):1320-4. PubMed ID: 24225966
[TBL] [Abstract][Full Text] [Related]
20. Electroretinographic Findings in Melanoma-Associated Retinopathy Treated by Intravitreal Dexamethasone Implant.
Abou-Samra A; Tzekov R; Yannuzzi NA; Tarabishy AB
Ophthalmic Surg Lasers Imaging Retina; 2021 Aug; 52(8):454-456. PubMed ID: 34410186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]